Composition for the treatment of fulminant acute pneumonia comprising a CD69 antagonist

摘要

It is an object of the present invention to provide an effective means for preventing and / or treating acute acute pneumonia. A drug or pharmaceutical composition used to prevent and / or treat acute acute pneumonia, comprising a CD69 antagonist, eg, an antibody that specifically recognizes CD69 (anti-CD69 antibody), specific for a CD69 antagonist, eg, CD69 Infiltration of neutrophils in the alveoli, including antibodies (anti-CD69 antibodies) that recognize the lungs, neutrophil infiltration in the lung, including CD69 antagonists, for example, antibodies that specifically recognize CD69 (anti-CD69 antibodies) There is provided a method for preventing and / or treating fulminant acute pneumonia, comprising administering an inhibitor and a CD69 antagonist such as an antibody that specifically recognizes CD69 (anti-CD69 antibody).